Senior Director of Global Patient Advocacy
Agios
Cambridge, Massachusetts, United States
Holly John serves as the Senior Director of Global Patient Advocacy at Agios, where she is renowned for her innovative and thoughtful leadership. Holly is dedicated to amplifying the voices of patients and ensuring their insights are integrated into every aspect of the company’s activities. Since being introduced to the Sickle Cell community in 2017, Holly has gained profound life lessons in resilience and gratitude, which have significantly influenced her approach to advocacy. With her extensive experience, Holly has built robust advocacy functions and teams that focus on the 'person' rather than the 'disease.' This patient-centered approach has not only brought immense value to her colleagues but also improved outcomes and experiences for patients. Her work reflects a deep commitment to fostering authentic partnerships with patients, patient advocates, and their clinicians. At Agios, Holly has defined a bold vision for patient-centricity that transcends mere rhetoric, driving tangible action and change. Her efforts have led to the successful launch of the Red Cell Revolution, an evidence-based advocacy initiative directed by patients, and the support of community efforts such as the ‘Nod to “Naz” Exhibit,’ a tribute to the inspiring work of Hertz Nazaire. These initiatives have garnered her recognition, including the SCAY Community Partner award. Holly’s ultimate goal is to elevate the standards of patient advocacy, ensuring that patients have a meaningful seat at the decision-making table.
Disclosure information not submitted.
Partnering with the Pharmaceutical Industry
Thursday, June 6, 2024
11:35 AM – 12:00 PM ET